Enanta Pharmaceuticals Inc. sell JPMorgan Chase & Co.
Start price
09.08.23
/
50%
€14.70
Target price
09.08.24
€12.75
Performance (%)
-25.17%
End price
10.08.24
€11.00
Summary
This prediction ended on 10.08.24 with a price of €11.00. The prediction for Enanta Pharmaceuticals Inc. closed with a convincing performance of -25.17%. JPMorgan_Chase___Co_ has a follow-up prediction for Enanta Pharmaceuticals Inc., but this time predicts that Enanta Pharmaceuticals Inc. is a Buy. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Enanta Pharmaceuticals Inc. | -5.128% | -5.128% | 130.290% |
| iShares Core DAX® | -1,74 % | 5,67 % | 7,84 % |
| iShares Nasdaq 100 | 2,81 % | 11,55 % | 36,61 % |
| iShares Nikkei 225® | -0,11 % | 9,65 % | 45,65 % |
| iShares S&P 500 | 0,97 % | 7,24 % | 26,97 % |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Enanta Pharmaceuticals Inc. diskutieren
Enanta Pharmaceuticals, Inc. (NASDAQ: ENTA) was downgraded by analysts at JPMorgan Chase & Co. from a "neutral" rating to an "underweight" rating. They now have a $14.00 price target on the stock.
Ratings data for ENTA provided by MarketBeat
In the thread Trading Enanta Pharmaceuticals Inc.
Die von JPMorgan_Chase___Co_ gewählte maximale Laufzeit wurde überschritten
Current prediction by JPMorgan_Chase___Co_ for Enanta Pharmaceuticals Inc.
Enanta Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€10.60
14.11.25
14.11.25
€14.61
14.11.26
14.11.26
11.32%
27.04.26
27.04.26
Stopped prediction by JPMorgan_Chase___Co_ for Enanta Pharmaceuticals Inc.
Enanta Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€11.50
06.08.24
06.08.24
€9.15
06.08.25
06.08.25
-47.83%
07.08.25
07.08.25